Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison
about
Risk factors for triple-negative breast cancer in women under the age of 45 yearsBody mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusHeight, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.Hormonal contraception and risk of cancer.Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis.Risk factors of breast cancer: a systematic review and meta-analysis.Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer studyReproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyA case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibilityAssociation of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women.Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation.Role of obesity in the risk of breast cancer: lessons from anthropometry.Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patientsEstrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.Can modulation of mammary gland development by dietary factors support breast cancer prevention?Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?A case-control study of oral contraceptive use and incident breast cancer.FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.A prospective study of smoking and breast cancer risk among African-American women.Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEERAn admixture scan in 1,484 African American women with breast cancer.A Matched Case-Control Study of Risk Factors for Breast Cancer Risk in Vietnam.Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry.Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease.Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women.Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.Epigenetic marks in estrogen receptor alpha CpG island correlate with some reproductive risk factors in breast cancer.Understanding rural-urban differences in risk factors for breast cancer in an Indian population.Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.
P2860
Q24644075-C686218A-1439-4166-8EB0-360868B26932Q27012792-3301A4FD-3B13-4DF0-A1D0-06CE9CF4F1CBQ33578863-469529BA-BB96-44AC-AC2E-392895689E6CQ33655313-57777576-E58E-4466-8413-340E72AA199BQ33763770-57F76640-DE86-44F1-B777-C82AF5B18C0BQ34057842-56016026-310B-4720-9DC8-A5F4F3E26DBDQ34120493-6274460F-D638-41E3-856E-33C665DA8FDFQ34341093-C4089A7C-BB5C-4F22-8DB0-36319F6EBE60Q34346863-22C52054-8A74-4D6E-AA18-303F47E9EEE0Q34447543-23724E5D-6FB6-48DF-B2E5-37B262770941Q35062955-EA601FBC-FEFD-4FA6-B5B4-73DFC0AEEA1BQ35174900-9C93AC44-9049-488C-9383-F0941839A171Q35184055-0530B772-7603-498E-8984-8E7392028869Q35195576-403539E3-C679-46EA-9A9A-F7E709C669D4Q35565644-52A8C69D-3A84-4EFA-B9D4-59628E1C85D1Q35576887-E457765D-F006-4700-A6D9-E8DF9B2D0D7DQ35605749-4B67C5AD-201D-49F5-90BE-054FCB5DE969Q36414193-0C0F2206-04D8-44F9-A7D9-0B1C1B0C656EQ36619166-2E4043FA-5274-4D89-B4BB-0D73F63C3F33Q36643111-BF6ABFB7-86C5-49C9-A63A-7D6AAE99E1D8Q36787353-0C9FBA58-986D-435A-94EF-880674ECE80CQ36825573-DBAB2E36-3641-474B-92E4-4968899B8945Q37196949-933A9102-858F-462A-A9F2-D8A3FC35B2D4Q37304563-0945CEBD-7F24-4186-A93E-4A91AA7656BEQ37323340-169EBBB2-7810-4387-85B7-67DB195F2F2CQ37373565-3E3892FC-CB1B-4EA2-B558-413F04E4D63FQ37379588-10761962-C5BB-41F0-BB5C-87CB9567CC8BQ37437960-4B19EC87-7E43-4ADD-B730-D962D135D0F5Q37533382-63DF87DA-23E2-4B96-9383-B815F58E91E5Q37586779-182F4F83-1D65-4FA7-A249-910AA9168D86Q37623331-6FBF98F3-3926-4837-B180-029EA09D3244Q37632099-DC3EDED2-507B-4E3C-96E8-B530361DAD30Q37978292-F70DD21E-F277-43F4-B7D3-1F61A665780AQ38060663-5D9CC487-21D9-4E26-8CF9-DDBAD83E6706Q38236180-E210A788-2834-43F0-AF26-67F89A410F9BQ38649483-BE31BB44-7D14-4606-8AA5-33DA75D55673Q39135183-EA789D99-15E6-4FC7-89B1-DA25F28E5D00Q39143225-56E6BC15-A5DD-4A7A-AA84-39F0B37E960FQ40295135-0055173D-1F56-4F08-B772-8439F5D6D212Q40518502-1772177A-A862-461B-8A71-415232EE2A37
P2860
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hormone-related risk factors f ...... rol and a case-case comparison
@ast
Hormone-related risk factors f ...... rol and a case-case comparison
@en
type
label
Hormone-related risk factors f ...... rol and a case-case comparison
@ast
Hormone-related risk factors f ...... rol and a case-case comparison
@en
prefLabel
Hormone-related risk factors f ...... rol and a case-case comparison
@ast
Hormone-related risk factors f ...... rol and a case-case comparison
@en
P2860
P356
P1476
Hormone-related risk factors f ...... rol and a case-case comparison
@en
P2093
Ronald K Ross
P2860
P2888
P356
10.1186/BCR1514
P577
2006-01-01T00:00:00Z
P5875
P6179
1011697102